Introduction Technology and connectivity are allowing audiological services to be provided in novel ways. The field of telehealth, although firmly established over the past two decades, is buoyed by the continued and rapid advances in information and communication technologies. Remote...
If you are an audiologist reading this article, how confident are you that all the information and advice that you offer your first-time hearing aid (HA) patients is understood, absorbed and then acted upon once they leave the comfort of...
All audiologists, I am sure, would claim that they give full explanations of hearing aid controls and use of the devices at all fitting appointments. However, we know that patients do not always absorb all that they are told and...
Kavita Prasad, the current CEO of Soundseekers, is an inspirational woman in a leadership role within the audiology world. Here, she gives us an overview of the scope of the charity and the ways in which they improve the lives...
What do hearing healthcare providers see as the benefits and barriers to delivering speech testing? This article explores the latest research. Why speech testing? Speech tests have been used across ENT and audiology practice to measure an individual’s speech recognition...
Neuromod Devices has launched its Lenire tinnitus treatment device in the United Kingdom, where it is estimated that seven million people suffer from tinnitus.
Grason-Stadler, a worldwide leader of clinical audiometric systems, hosted a conversation with Dr James W Hall III and Dr Robert Margolis to discuss the current landscape around the patient-provider gap and the essential need for an automated tool.
Today, Signia UK and The Audiology Academy have announced an exclusive partnership designed with the intention to create better access to high quality training for Hearing Care Professionals in the UK.
AURITEC AT2000 is a state-of-the-art audiometer that stands out for its exceptional capabilities in multichannel audiometry and its unique integration with cochlear implants.